← All organizations

AOP Orphan Pharmaceuticals AG

For profitContributed to NMEWebsite ↗

Also known as: Activartis Biotech | AOP Contract Clinical Research Facility | AOP Orphan Pharmaceuticals AG | AOP ORPHAN PHARMACEUTICALS GMBH

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

First NDA

Last known activity

Nov 22, 2024

Timeline

1990s

Jul 1, 1996
AOP Orphan Pharmaceuticals AG— Founded

2020s

Nov 22, 2024
landiolol— NDA Organization

Drugs by trial phase (15 distinct, 18 trials)

Phase 3 (5 own, 0 via acquisition)

Phase 2 (6 own, 0 via acquisition)

Phase 1 (4 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

landiolol

Recent trials (21)

NCT06350032Lead sponsorPhase 3Jul 31, 2024
NCT06514807Lead sponsorPhase 3Dec 4, 2023
NCT03117816CollaboratorPhase 2Apr 26, 2017
NCT03003325CollaboratorPhase 2Feb 2, 2017
NCT02523638Lead sponsorPhase 3Jul 1, 2015
NCT02218047Lead sponsorPhase 3Nov 1, 2014
NCT02076815Lead sponsorPhase 3Feb 1, 2014
NCT01949805Lead sponsorPhase 3Sep 1, 2013
NCT01933906CollaboratorPhase 1Aug 1, 2013
NCT01741519Lead sponsorPhase 1Dec 1, 2012
NCT01652898Lead sponsorPhase 1Jul 1, 2012
NCT01313143Overall official - principal investigatorPhase 2Mar 1, 2011
NCT01313143Lead sponsorPhase 2Mar 1, 2011
NCT01230775Study directorPhase 3Dec 1, 2010
NCT01230775Lead sponsorPhase 3Dec 1, 2010

Details

Founded: Vienna, AT Jul 1, 1996
First NDA: Nov 22, 2024
Last known activity: Nov 22, 2024